10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -255,099 | -206,147 | -113,161 | -50,747 | -166,000 |
| Depreciation Amortization | 43,619 | 31,913 | 20,493 | 8,616 | 33,006 |
| Accounts receivable | -10,613 | 361 | 16,526 | 26,279 | -18,948 |
| Accounts payable and accrued liabilities | -6,017 | -2,811 | 1,314 | -781 | 5,858 |
| Other Working Capital | 18,021 | 277 | -15,893 | -5,960 | -40,342 |
| Other Operating Activity | 194,892 | 135,452 | 75,070 | 18,468 | 152,820 |
| Operating Cash Flow | $-15,197 | $-40,955 | $-15,651 | $-4,125 | $-33,606 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 183,016 | 166,468 | 146,132 | 125,238 | -215,226 |
| PPE Investments | -48,601 | -45,151 | -29,915 | -4,559 | -131,661 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -4,000 |
| Purchase Sale Intangibles | -923 | -923 | -723 | -723 | N/A |
| Other Investing Activity | -923 | -923 | -723 | -723 | 0 |
| Investing Cash Flow | $133,492 | $120,394 | $115,494 | $119,956 | $-350,887 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,814 | -5,814 | -5,814 | -5,814 | -5,409 |
| Common Stock Issued | 19,483 | 13,870 | 9,496 | 2,400 | 21,226 |
| Financing Cash Flow | $13,669 | $8,056 | $3,682 | $-3,414 | $15,817 |
| Exchange Rate Effect | -33 | -110 | -25 | 24 | -44 |
| Beginning Cash Position | 227,353 | 227,353 | 227,353 | 227,353 | 596,073 |
| End Cash Position | 359,284 | 314,738 | 330,853 | 339,794 | 227,353 |
| Net Cash Flow | $131,931 | $87,385 | $103,500 | $112,441 | $-368,720 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,197 | -40,955 | -15,651 | -4,125 | -33,606 |
| Capital Expenditure | -48,601 | -45,151 | -29,915 | -4,559 | -131,661 |
| Free Cash Flow | -63,798 | -86,106 | -45,566 | -8,684 | -165,267 |